Porphyromonas gingivalis lipopolysaccharide (LPS) is a crucial virulence factor strongly involved in the development of chronic periodontitis. It displays a significant amount of lipid A structural heterogeneity, containing both tetra-(LPS 1435/1449 ) and penta-acylated (LPS 1690 ) lipid A structures with opposing effects on E-selectin expression in human endothelial cells. Little is known about how these two isoforms of P. gingivalis LPS could differentially affect host innate immune responses in human gingival epithelia. The present study compares the modulatory effects of P. gingivalis LPS 1435/1449 and LPS 1690 on the expression of human b-defensins (hBDs) in the reconstituted human gingival epithelium, and examines the involvements of a panel of pattern recognition receptors in the modulatory effects concerned. It is shown that hBD-1, hBD-2 and hBD-3 mRNAs are significantly up-regulated by P. gingivalis LPS 1690 , but down-regulated by P. gingivalis LPS 1435/1449 . Toll-like receptor (TLR) 2 and CD14 mRNAs are also differentially regulated, and the modulation of hBD-2 expression may be through the co-operation of both TLR2 and TLR4. This study suggests that P. gingivalis LPS with different lipid A structures could differentially modulate host innate immune responses in human gingival epithelia, which may be a hitherto undescribed novel pathogenic mechanism of P. gingivalis in periodontal pathogenesis.
INTRODUCTION
Human gingival epithelium, the first barrier of periodontal tissues, is constantly challenged by a variety of oral micro-organisms. Apart from the physical barrier function, it also provides protection against microbial invasion by secreting an array of antimicrobial peptides, such as human b-defensins. [1] [2] [3] Human b-defensins (hBDs) are a group of small, cationic, cysteine-rich peptides with potent antimicrobial activity against both Gram-positive and Gram-negative bacteria, fungi, and viruses. 4, 5 Besides killing micro-organisms, hBDs have been demonstrated to promote adaptive immune responses by selectively recruiting immature dendritic and memory T-cells to the site of microbial invasion. 6, 7 To date, four forms of hBDs (hBD-1-4) have been identified in humans, with hBD-1, hBD-2 and hBD-3 detected in all human epithelial tissues including gingival epithelia. 1, 2 Their expression is either constitutive or regulated in response to microbial or pro-inflammatory stimuli. [8] [9] [10] For instance, hBD-1 and hBD-3 mRNA expression could be induced by different strains of Porphyromonas gingivalis in periodontal pocket epithelial cells. 11 Human b-defensin-2 mRNA expression is up-regulated strongly by Escherichia coli lipopolysaccharide (LPS) in airway and vaginal epithelial cells, 12, 13 whereas it is weakly or sporadically induced in gingival and organotypic epidermal keratinocytes. 14, 15 Lipopolysaccharide is a major surface antigen of Gram-negative bacteria and one of the most powerful microbial products in terms of pro-inflammatory activities. Recognition of LPS by host innate immune system could lead to uncontrollable cytokine production, which may contribute to various inflammatory diseases in humans. Porphyromonas gingivalis is a Gram-negative bacterium that has been considered to be a key periodontal pathogen due to its strong correlation with periodontitis. 16 Porphyromonas gingivalis LPS is one of the crucial virulence factors of this pathogen and it is significantly involved in the pathogenesis of periodontal disease. 17, 18 Compared with the well-defined activity of E. coli LPS, P. gingivalis LPS has been shown to be less biologically reactive and to elicit different host responses which are responsible for the mechanisms to evade, or even inhibit, the host immune defense system. 19, 20 Recently, P. gingivalis LPS has been found to be highly heterogeneous and contains both tetra-and penta-acylated lipid A structures. 21 It has been shown that penta-acylated lipid A structures facilitate E-selectin expression, whereas tetra-acylated lipid A structures do not. 22 Therefore, the presence of multiple lipid A structures may represent an adaptation made by P. gingivalis in response to the alteration of local host micro-environments. 22 Currently, little information is available on how these two isoforms of P. gingivalis LPS could differentially affect host innate immune responses in human gingival epithelia.
The present study compares the modulatory effects of P. gingivalis LPS 1435/1449 and LPS 1690 lipid A structures on the expression of hBDs in the reconstituted human gingival epithelium, and examines the possible involvement of a panel of pattern recognition receptors in the modulatory effects concerned.
MATERIALS AND METHODS

Reconstituted human gingival epithelium model
An area of 0.5 cm 2 human gingival epithelium (Skinethic Laboratories, Nice, France) was reconstituted by airlifted culture of normal human gingival keratinocytes (second passage) for 5 d in a serum-free growth medium on inert polycarbonate filters, which was histologically similar to the cell layers of human gingival epithelium. 23 Upon arrival, reconstituted human gingival epithelium (RHGE) was stored in an incubator at 37 C, 5% CO 2 , and saturated humidity in the growth medium (Skinethic Laboratories) containing insulin (5 mg/ml), calcium chloride (1.5 mM), gentamycin (25 mg/ml), and hydrocortisone (0.4 mg/ml). After 24 h, they were used for the subsequent tests.
Preparation of LPS and LPS stimulation
Porphyromonas gingivalis LPS was isolated from P. gingivalis ATCC 33277 and prepared by the cold MgCl 2 -ethanol procedure as previously described, based upon the protein digestion of whole-cell extracts with proteinase K and successive solubilization and precipitation procedures. 21, 22, 24 The LPS was further purified to remove trace amounts of endotoxin protein; the final protein contamination was less than 0.1%. The fatty acids present in the P. gingivalis LPS were analyzed by gas chromatography-mass spectroscopy. 21, 22 Then matrix-assisted laser desorption ionization time-offlight mass spectrometry was performed as previously described, 25 and two separate extractions of P. gingivalis LPS with tetra-(LPS 1435/1449 ) and penta-acylated (LPS 1690 ) lipid A structures were produced and analyzed. Escherichia coli O55:B5 LPS was purchased from Sigma (St Louis, MO, USA). In the dose-dependent assay, RHGE was treated with P. gingivalis LPS 1435/ 1449 , P. gingivalis LPS 1690 or E. coli LPS in the media at various concentrations (1 ng/ml, 10 ng/ml, 100 ng/ml, 1 mg/ml, and 10 mg/ml) for 24 h. Based on these results, 10 mg/ml of P. gingivalis LPS 1435/1449 and LPS 1690 , and 10 ng/ml of E. coli LPS were selected for the subsequent time-dependent assay, in which RHGE was treated for 2, 6, 12, 18, 24, 36, 48, 72 and 96 h. Reconstituted human gingival epithelium model incubated with culture medium alone was used as the negative control. The RHGE was then harvested and divided into three parts: one-third was fixed in 4% paraformaldehyde, dehydrated and embedded in paraffin for immunohistochemistry, and the other two-thirds were kept at À70 C for subsequent extraction of total RNA and protein, respectively.
Immunohistochemistry
The embedded samples were routinely sectioned to yield 4-mm thick specimens. Serial paraffin sections were deparaffinized, rehydrated and then soaked in deionized water containing 3% hydrogen peroxide for 10 min to block endogenous peroxides. Non-specific binding was blocked for 30 min with 3% bovine serum albumin (Sigma) in Tris-buffered saline. The sections were then incubated at 4 C for 18 h with goat polyclonal IgG antibodies to hBD-1 and hBD-2 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and rabbit antihuman hBD-3 polyclonal IgG (Sage BioVentures Inc., Carlsbad, CA, USA) at a 1:200, 1:100 and 1:500 dilution, respectively. The hBD-1-3 antibodies preincubated in an excess of recombinant hBD-1-3 (Research Diagnostics Inc., Flanders, NJ, USA), respectively, were added as the negative controls. After incubation with biotinylated secondary antibodies, the reactions were detected using an avidin-biotin peroxidase complex kit (DakoCytomation, Glostrup, Denmark). Visualization was performed using 3,3diaminobenzidine (Sigma). The expression levels of hBDs were recorded as mild (þ), moderate (þþ) and intensive (þþþ), which were evaluated by a single investigator and verified by another investigator who was blinded for the details of the experiment.
Reverse transcription-PCR (RT-PCR) assay and real-time PCR analysis
For RT-PCR, total RNA was extracted from homogenized RHGE using RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. One microgram of total RNA from each sample was reverse transcribed into cDNA in a final volume of 20 ml using the SuperScript TM First-Strand Synthesis System (Invitrogen Corp., Carlsbad, CA, USA). mRNAs from hBDs-1-3 were detected in a final volume of 50 ml containing 50 ng cDNA of template, 0.4 mmol/l of each primer of the target genes, 0.2 mmol/l of each primer of b-actin, 0.16 mmol/l of each dNTP, 1 Â PCR buffer, 1.5 mmol/l MgCl 2 and 2 U Taq DNA polymerase (Invitrogen Corp.). b-Actin, a housekeeping gene, was amplified together with the target gene as an internal control. After 26-28 cycles of amplification, an aliquot (15 ml) of each PCR product was subjected to gel electrophoresis on a 1.5% agarose gel and visualized by ethidium bromide staining, and then scanned using the Uvidoc gel documentation system (Bio-Rad Laboratories, Hercules, CA, USA). To quantify the mRNAs of hBDs-1-3, CD14, TLR2, TLR4, MD2 and MyD88, real-time PCR was performed using the StepOne Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). Amplification reactions were performed in a final volume of 20 ml containing 10 ml of Power SYBR Õ Green PCR Master Mix (Applied Biosystems), 50 ng cDNA templates, and 0.25 mM of each primer of the target genes (Sigma). b-Actin was amplified as an internal control. The specific sequences for each pair of primers are listed in Table 1 . The reaction conditions were set at 95 C for 10 min followed by 40 cycles at 95 C for 15 s and 60 C for 1 min. The results were analyzed using the comparative cycle threshold (Ct) method, 10 based upon the assumption that the target and reference primers amplify with the same efficiency within a given range of cDNA template concentrations. The expression level for each gene was normalized to b-actin (ÁCt) and fold changes for each gene were calculated as 2 ÀÁÁCt , by comparing the treated RHGE with untreated RHGE (normalized to 1) from the ÁÁCt value.
Enzyme-linked immunoadsorbent assay (ELISA)
Total proteins were extracted from homogenized RHGE using CelLytic TM -M reagent (Sigma), and their concentrations were measured with Bio-Rad's protein assay according to the manufacturer's instructions. The expression level of hBD-2 peptide in the total proteins was determined by ELISA (Phoenix Pharmaceuticals, Inc., Belmont, CA, USA), with a minimum detectable concentration of 7.82 pg/ml and without cross-reactivity or interference with recombinant hBD-1 or hBD-3. The absorbance values were determined by a microplate reader (Bio-Rad 3550, Tokyo, Japan) at an optical absorbance of 450 nm. Afterwards, the concentration of hBD-2 peptide was determined with reference to a standard curve for human recombinant hBD-2 and the results were presented as pg/mg of total protein. 
Blocking assay against TLR2, TLR4, and CD14 receptors
For blocking assay, RHGE was pre-incubated for 1 h with specific blocking anti-human TLR2 (eBioscience Inc., San Diego, CA, USA), TLR4 (eBioscience) and CD14 (eBioscience) monoclonal antibodies at 10 mg/ml, prior to incubation with E. coli LPS (10 ng/ml) for 2 h and P. gingivalis LPS (10 mg/ml) for 24 h. The RHGE incubated with medium alone was used as the negative control, and RHGE incubated with LPS without preincubation with antibodies was used as the positive control. After the LPS stimulation, RHGE was harvested, divided into two parts, and kept at À70 C for subsequent extraction of total RNA and protein, respectively.
Statistical analysis
All experiments were repeated in at least two batches of RHGE with comparable results and the results were presented as mean AE SD. Statistical significance was determined using the independent t-test. A P-value of50.05 was considered statistically significant.
RESULTS
The expression of hBD peptides in RHGE by immunohistochemistry
Peptide expression of hBDs-1-3 was basally detected in the control RHGE ( Fig. 1 ). Human b-defensin-1 ( Fig. 1a ) and hBD-2 ( Fig. 1b) were mainly expressed in the upper and middle layers of RHGE, whereas hBD-3 ( Fig. 1c ) was mainly located in the basal layers. Compared with hBD-2 and hBD-3, hBD-1 ( Fig.  1a,d ,g,j) was consistently expressed at a lower level in both treated and untreated RHGE ( Table 2 ). Human bdefensin-2 and hBD-3 were expressed at a moderate level in the control RHGE, whereas they were faintly expressed in the RHGE stimulated with P. gingivalis LPS 1435/1449 ( Fig. 1e ,f), moderately with P. gingivalis LPS 1690 (Fig. 1h ,i), and intensively with E. coli LPS ( Fig. 1k ,l; Table 2 ).
Human -defensin mRNAs were differentially regulated by P. gingivalis LPS 1690 and LPS 1435/1449
Messenger RNAs from hBDs-1-3 were basally expressed in RHGE. As shown in Figure 2 , after 24-h stimulation, their expression levels were significantly up-regulated by 10 mg/ml of P. gingivalis LPS 1690 and the effect on hBD-2 was about 5-6-fold that on hBD-1 and hBD-3. In contrast, mRNA expression of hBDs-1-3 was significantly down-regulated by P. gingivalis LPS 1435/1449 . Escherichia coli LPS did not significantly affect mRNA expression of hBDs.
Human was also observed in the RHGE stimulated by 10 ng/ml of E. coli LPS. Based upon the above results, 10 mg/ml and 10 ng/ml were selected, respectively, as the optimal concentrations for the subsequent studies on P. gingivalis LPS and E. coli LPS.
Messenger RNAs of hBDs-1-3 were up-regulated by P. gingivalis LPS 1690 and E. coli LPS at different time points
As shown in Figure 4 , mRNAs of hBDs-1-3 were consistently expressed in the control RHGE during 96-h observation, whereas they were significantly up-regulated by P. gingivalis LPS 1690 after 12-h stimulation, reaching plateaus at 24 h (hBD-1 and hBD-2) or 36 h (hBD-3), and remaining up-regulated for up to 72 h. In contrast, the up-regulation of hBD mRNAs by E. coli LPS was more prompt. Both hBD-2 and hBD-3 mRNAs were up-regulated to peak levels within 2 h, and then gradually decreased to basal levels within 36 h in a timedependent fashion; hBD-1 mRNA showed a different pattern in response to E. coli LPS, being up-regulated at 2 h, reaching peak at 36 h and then decreasing to basal level at 96 h.
Differential effects on TLR2 and CD14 mRNA expression by P. gingivalis LPS 1690 and LPS 1435/1449
Toll-like receptor 2, CD14, MD2, and MyD88 mRNAs were basally expressed in RHGE. As shown in Table 3 Fig. 5a ), whereas TLR4, CD14, or both TLR2 and TLR4 antibodies significantly blocked the P. gingivalis LPS 1690 -induced up-regulation of hBD-2 mRNA expression ( Fig. 5b) .
DISCUSSION
Recent studies have shown that human gingival epithelial cells in both periodontal health and disease are able to produce hBDs. 1, 2, 11, 26 Little is known on how hBD expression is regulated upon the insult of periodontal pathogens or their products. Reconstituted human gingival epithelium is a reproducible model which is histologically similar to the cell layers of human gingival epithelium for examination of the behavior of gingival epithelial cells. 23 Using this model, the present study for the first time provides novel information on the different regulatory effects of the two isoforms of P. gingivalis LPS 1435/1449 and LPS 1690 on the expression of hBDs-1-3 in human gingival epithelia. It was shown that the expression profiles of hBDs-1-3 peptides in RHGE were consistent with their in vivo expression patterns. 1, 2 Messenger RNAs of hBDs-1-3 were constantly expressed throughout the experimental period, indicating that RHGE maintains its viability for up to 96 h and continues to function properly over the period of study. The observation on differential regulatory effects of P. gingivalis LPS 1435/1449 and LPS 1690 on the expression of hBD mRNAs suggests that gingival innate immune response could be modulated by the two isoforms of P. gingivalis LPS through regulation of hBD expression at a transcriptional level. The incongruent effects on hBD-2 mRNA and peptide expression by P. gingivalis LPS 1690 may be due to its interference on hBD-2 synthesis, or merely a result of biological discrepancy in gene expression and the relevant protein production at a given time point. 27, 28 If the former assumption is proven correct, and in combination with the direct inhibitory effect on hBD-2 by P. gingivalis LPS 1435/1449 , both isoforms of P. gingivalis LPS may contribute to the evasion of P. gingivalis from host innate defense. Inhibition of hBD production at sites of bacterial invasion in epithelial cells could impair the antimicrobial activity, and hence facilitate bacterial overgrowth and invasion, thereby initiating periodontal tissue destruction. Further study is warranted to clarify this point.
Escherichia coli LPS is known to be a potent inducer of hBD-2 in gingival epithelial cells. 9, 14 In the present β-actin 0h 2h 6h 12h 18h 24h 36h 48h 72h 96h 0h 2h 6h 12h 18h 24h 36h 48h 72h 96h 0h 12h 18h 24h 36h 48h 72h 96h hBD-1 β-actin hBD-2 β-actin hBD-3 P. gingivalis LPS 1690 ( time-dependent assay, RHGE exhibits a relatively prompt responsiveness to E. coli LPS, but a higher and persistent responsiveness to P. gingivalis LPS 1690 . It is, therefore, crucial to find out the appropriate time point of observation when one examines host response to LPS. Thus, 24-h stimulation, which is generally used in most of the studies on bacterial LPS, is possibly too long for a positive result to be achieved for hBDs. Recognition of LPS is a key event in innate host antimicrobial defense. Lipopolysaccharide signaling in human cells is commonly initiated by CD14 and TLRs. 29, 30 Porphyromonas gingivalis LPS 1435/1449 and LPS 1690 appeared to interact with CD14 differently. First, they exhibited different effects on CD14 expression in RHGE. Second, blocking CD14 function significantly inhibited the P. gingivalis LPS 1690 -induced up-regulation of hBD-2 mRNA, but it had no effect on its down-regulation by P. gingivalis LPS 1435/1449 . These observations suggest that CD14 may contribute to the regulation of hBD-2 expression by P. gingivalis LPS 1690 , whereas it may not be directly involved in the downregulation of hBD-2 by P. gingivalis LPS 1435/1449 . It could be speculated that P. gingivalis LPS 1435/1449 may bind additional LPS receptors other than CD14, such as heat shock proteins 70 and 90, chemokine receptor 4 and growth differentiation factor 5, 31 to initiate the downstream modulation of hBD-2.
Although CD14 has been identified as a LPS receptor, additional transmembrane receptors are needed to act in concert with LPS-CD14 complexes to initiate intracellular signaling, since the glycerophosphate inositol anchor of CD14 lacks transmembrane and intracellular domains. Much evidence indicates that TLR4, instead of TLR2, is involved in the innate immune response to E. coli LPS. 32, 33 Yet, recent studies indicate that P. gingivalis LPS could activate cells by functionally interacting with both TLR2 and TLR4. 21, 34 It is evident that TLR2 and TLR4 could be expressed in human gingival epithelia. [35] [36] [37] [38] In the present study, both TLR2 and TLR4 mRNAs were up-regulated by P. gingivalis LPS and E. coli LPS. It was interesting to find that blocking TLR4 function significantly inhibited the modulatory effects of P. gingivalis LPS 1435/1449 and LPS 1690 on hBD-2 mRNA expression, implying a crucial role of TLR4 in the regulation of hBD-2 by P. gingivalis LPS. As blocking both TLR2 and TLR4 function resulted in a significant inhibition of P. gingivalis LPS effects on hBD-2, it could be speculated that a cooperation of TLR2 and TLR4 may be more effective in mediating the LPS-induced transmembrane signaling pathways. Toll-like receptor 2 has multiple partners with which it can combine to form functional complexes. Two known TLR family members that can form heterodimers with TLR2 are TLR1 and TLR6. The expression level for each gene was normalized to b-actin and fold changes for each gene were calculated by comparing the treated RHGE with untreated RHGE (normalized to 1). *P50.05, **P50.01, ***P50.001.
These transient associations of different receptors could allow the host to tailor the response to individual pathogens by producing specific patterns of inflammatory mediators. 39 It could, therefore, be hypothesized that although the two isoforms of P. gingivalis LPS have differential effects on hBD expression, the regulation of hBD-2 by both isoforms of LPS may be mediated by a signaling pathway probably co-elicited by both TLR2 and TLR4. Further study is warranted to clarify this hypothesis.
CONCLUSIONS
The mRNA expression of hBDs-1-3 in RHGE was significantly up-regulated by P. gingivalis LPS 1690 , but down-regulated by P. gingivalis LPS 1435/1449 . The effects of P. gingivalis LPS with different lipid A structures on the expression of CD14 and TLR2 mRNA differed as well, indicating differential modulatory effects of P. gingivalis LPS on gingival innate immune responses. Given that one isoform of LPS may predominate over others in certain micro-environments and the recent findings on hemin-dependent modulation of the lipid A structure of P. gingivalis LPS, 40 it is understandable that the presence of P. gingivalis in the periodontal niche does not necessarily cause periodontal destruction. Interestingly, the up-regulation of hBD-2 mRNA in the RHGE stimulated with P. gingivalis LPS 1690 was not followed by an increased production of hBD-2 peptide; in addition, hBD-2 peptide was downregulated by P. gingivalis LPS 1435/1449 . These findings suggest the possibility of a hitherto undescribed novel pathogenic mechanism of P. gingivalis in periodontal pathogenesis. In addition, the regulation of hBD-2 expression by both isoforms of P. gingivalis LPS may be through TLR2 and TLR4. CD14 may also be involved in the regulation of hBD-2 by P. gingivalis LPS 1690 . The present findings facilitate further understanding of the possible mechanisms of P. gingivalis and gingival epithelium interactions and add to the current knowledge base for the development of novel therapeutic approaches against periodontal disease. 
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